Although the underlying mechanism remains elusive, nonresponder hepatitis C patients tend to have pre-activated Jak-STAT pathway prior to therapy, which may connect to IFN refractoriness [27]. The gene discussed is SOAT1; the disease is hepatitis C virus infection.